Can a nation effectively separate its fiscal health from the mechanics of its medical marketplace? For years, the conversation surrounding the federal budget and the cost of care has been siloed, treated as two distinct policy challenges. Yet, a closer look at the structural underpinnings of the American economy suggests that our mounting national debt and our world-leading health care costs are, in reality, the same crisis manifesting in different sectors.
The Cato Institute recently released a “Handbook on Affordability,” a resource that attempts to map the root causes of these parallel pressures. The fundamental fiscal question is how the government manages its obligations when the trajectory of debt outpaces the growth of the broader economy. As contributors Romina Boccia and Dominik Lett argue, when this imbalance occurs, investors essentially wait for one of three signals: higher future taxes, deeper spending cuts, or an inflationary environment that erases the real value of government debt.
While headlines often focus on the immediate political friction regarding spending, the reality is that when Congress fails to commit to tax increases or spending discipline, it defaults to the third option: inflation. The surge of 2021 serves as a clear case study, acting as the direct consequence of deficit-financed spending without a long-term repayment strategy. As the dollar’s purchasing power eroded, the Federal Reserve was forced to pivot toward sharper interest rate hikes, which in turn compounded the financial strain on households and the government alike.
The Mathematical Weight of Entitlement Programs
The fiscal dilemma is not spread evenly across the federal budget. It is concentrated in two primary engines: Social Security and Medicare. The former carries approximately $28 trillion in unfunded obligations, while the latter is projected to grow indefinitely at a rate that exceeds the economy’s expansion.
The study highlights a grim mathematical certainty: without structural reform, these programs do not possess a natural ceiling. This creates a feedback loop where the debt path remains unsustainable, effectively cementing the inflation risk identified by Boccia and Lett. If we continue to view these obligations through the lens of current policy, the prospect of future inflationary cycles becomes not just a possibility, but a statistical inevitability.
Why Subsidies May Be Fueling the Fire
This fiscal instability intersects directly with the American health care system, where the U.S. currently spends nearly 18.5% of its national income on medical services. This figure is significant not just for its size, but for its contrast; it is double the average seen in other wealthy OECD democracies.
A common political response is to introduce further government subsidies to shield patients from rising costs. However, contributors Michael Cannon and Jeffrey Singer posit a contrarian view: these subsidies are not the solution, but rather the primary catalyst for unaffordability. By insulating patients from the actual cost of care—through the dominant influence of Medicare, Medicaid, and private insurance mandates—the market loses the feedback loop that typically disciplines prices. When consumers are not price-sensitive, providers lose the incentive to compete on cost, leaving the system to drift toward higher premiums and taxes without a corresponding increase in the quality of outcomes.
Clearing the Path for Supply-Side Reform
If the current regulatory architecture is the engine of high costs, the solution may lie in supply-side liberalization. The research points to federal health-insurance regulations that effectively double premiums for many consumers, suggesting that deregulation could yield substantial price relief.
Furthermore, the current framework places significant weight on the FDA’s monopoly over drug approvals, which keeps medications already cleared in markets like Australia, Canada, and Europe out of the United States. Expanding recognition of foreign certifications or removing prescription requirements for safe, self-administered medicines could introduce the competition necessary to drive down costs.
The next reading of the federal debt-to-GDP ratio and the upcoming updates to Medicare’s long-term financial projections will determine whether these structural imbalances remain the defining feature of the American economy. Addressing this will require moving past the current reliance on subsidies and toward a dismantling of the regulatory barriers that have insulated the health care market from genuine competition.
